Figure 6.
Effect of Saroglitazar on lipids in hApoB100/hCETP double transgenic mice (A) effect on % change in serum LDL-C versus control (B) effect on % change in serum total cholesterol versus control. Animals were treated with Saroglitazar for 14 days at 0.1, 0.3, 1, 3, and 10 mg/kg. The values are calculated as percent change versus control and expressed as mean ± SEM (n = 6).